Continuous artificial intelligence-assisted DNA aneuploidy cytology for surveilling dysplastic oral leukoplakia treated by photodynamic therapy

Photodiagnosis Photodyn Ther. 2023 Jun:42:103588. doi: 10.1016/j.pdpdt.2023.103588. Epub 2023 Apr 29.

Abstract

Oral leukoplakia (OLK) is one of the most common potentially malignant disorders. High-risk lesions require early intervention before developing into oral cancer. Photodynamic therapy (PDT) is a noninvasive technique for premalignant lesions. Scalpel biopsy remains a reliable method for monitoring the prognosis of OLK, but it is an invasive procedure with poor reproducibility to suspicious lesions. DNA aneuploidy cytology by oral cytobrush has been proposed as a promising objective and noninvasive tool in screening and diagnosing premalignant and malignant lesions. Here, we discussed the significance of artificial intelligence (AI)-assisted DNA aneuploidy cytology by image cytometry (DNA-ICM) for surveilling non-homogeneous OLK with moderate-to-severe dysplasia that was treated by 5-aminolevulinic acid-mediated PDT (ALA-PDT). The present study provides a scheme of the sequential management and surveillance strategy for OLK.

Keywords: Artificial intelligence; DNA aneuploidy cytology; Oral leukoplakia; Photodynamic therapy; Sequential surveillance.

Publication types

  • Case Reports

MeSH terms

  • Aneuploidy
  • Artificial Intelligence
  • DNA
  • Humans
  • Leukoplakia, Oral / drug therapy
  • Leukoplakia, Oral / pathology
  • Photochemotherapy* / methods
  • Photosensitizing Agents* / therapeutic use
  • Reproducibility of Results

Substances

  • Photosensitizing Agents
  • DNA